Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

142
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
142
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

316
Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
316
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

208
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
208
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

205
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
205

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between chronic rhinosinusitis, bronchiectasis and type 2 inflammation: an EMBARC registry analysis.

ERJ open research·2026
Same author

Vasculopathy as a mechanical barrier to cancer spread: Clinical evidence and a rheology-based model in lung cancer and other solid tumors.

Translational oncology·2026
Same author

Automated high-resolution CT analysis outperforms visual assessment in predicting interstitial lung disease progression in SSc.

Rheumatology (Oxford, England)·2026
Same author

Evaluating current bronchiectasis care in Italy according to the 2025 European respiratory society recommendations.

Therapeutic advances in respiratory disease·2026
Same author

Athletic Intervention After Thoracic Surgery for Lung Cancer: Rationale and Design of the ATHENA Study.

Health science reports·2026
Same author

Inflammatory endotypes in immunocompromised patients with community-acquired pneumonia: a framework for treatable traits.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026

Related Experiment Video

Updated: Jun 30, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

430

Diagnostic delay in bronchiectasis: an Italian perspective.

Carlo Chessari1, Edoardo Simonetta2, Francesco Amati2,3

  • 1PROMISE Department, University of Palermo, Palermo, Italy.

ERJ Open Research
|March 19, 2024
PubMed
Summary

Patients with bronchiectasis experience a significant diagnostic delay of approximately 3.5 years from symptom onset. This highlights the long patient journey and challenges in diagnosing this chronic respiratory condition.

More Related Videos

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

80.7K
Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting
04:47

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting

Published on: June 23, 2023

2.4K

Related Experiment Videos

Last Updated: Jun 30, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

430
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

80.7K
Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting
04:47

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting

Published on: June 23, 2023

2.4K

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Clinical Diagnosis

Background:

  • Bronchiectasis is a chronic respiratory condition characterized by permanent enlargement of the bronchi.
  • Early diagnosis and treatment are crucial for managing bronchiectasis and preventing disease progression.
  • The patient journey from symptom onset to diagnosis is often prolonged, impacting clinical outcomes.

Purpose of the Study:

  • To investigate the time delay between symptom onset and diagnosis of bronchiectasis in Italy.
  • To understand the factors contributing to the delayed diagnosis of bronchiectasis.
  • To identify potential areas for improving the diagnostic pathway for bronchiectasis patients.

Main Methods:

  • Retrospective analysis of patient data in Italy.
  • Review of medical records to identify symptom onset and diagnosis dates.
  • Statistical analysis to calculate the mean diagnostic delay.

Main Results:

  • The average time from symptom onset to bronchiectasis diagnosis was approximately 3.5 years.
  • Significant delays were observed across different patient demographics and symptom presentations.
  • This extended delay suggests challenges in recognizing early symptoms and accessing timely medical evaluation.

Conclusions:

  • A substantial diagnostic delay exists for bronchiectasis patients in Italy.
  • Interventions aimed at increasing awareness and facilitating earlier diagnosis are warranted.
  • Improving the diagnostic pathway can lead to better management and improved quality of life for individuals with bronchiectasis.